Liver disease is a major public health problem in the world and China, and its theoretical innovation and technological progress in the field of diagnosis and treatment are changing with each passing day. In response to the World Health Organization's goal of eliminating the harm of viral hepatitis by 2030, further improve the clinical skills and academic level of liver disease diagnosis and treatment professionals in the southwest region, and promote the exchange and sharing of experience in liver disease diagnosis and treatment across regions. After research, the cloud classroom series of mugan Hengxing - Yunling Qianshan "Yu" to see new knowledge - liver disease diagnosis and treatment, hosted by Chengdu high tech Medical Association, will be held online from January to December 2026, with a total of three sessions.

The purpose of this series of meetings is to provide a professional, standardized and innovative academic exchange platform for medical staff in Southwest China, and promote the improvement of clinical research and clinical diagnosis and treatment in the field of liver disease.

Guided by professionalism, standardization and innovation, the series will gather authoritative experts in the field of liver diseases in China to carry out in-depth sharing and Discussion on the accurate diagnosis, standardized treatment, long-term management and application of new technologies for common liver diseases such as viral hepatitis, fatty liver, liver cirrhosis and liver cancer. Through authoritative lectures, case analysis, hot topic discussion and other forms, the cutting-edge concepts are closely combined with clinical practice to help improve the homogenization and standardization of liver disease diagnosis and treatment in Southwest China.

The implementation of this cloud classroom series meeting is not only the implementation of the healthy China strategy and the goal of global hepatitis elimination, but also an important measure to promote the coordinated development of liver diseases in Southwest China. The activity will effectively break the geographical restrictions, reduce the learning threshold, enable more grass-roots and clinical front-line medical staff to easily access high-quality academic resources, continue to improve the regional liver disease prevention and treatment ability, provide more scientific and efficient medical services for patients with liver diseases, and protect the liver health of the people with academic strength.

Chengdu high tech Medical Association will take this series of meetings as an opportunity to continue to build a high-level academic exchange bridge, gather industry consensus and expert wisdom, help the high-quality development of liver disease prevention and control in China, and contribute to the southwest to achieve the goal of eliminating the harm of viral hepatitis by 2030.